109 related articles for article (PubMed ID: 3136793)
1. Transmission of hepatitis B by dry heat treated factor VIII and IX concentrates.
Lush CJ; Chapman CS; Mitchell VE; Martin C
Br J Haematol; 1988 Jul; 69(3):421. PubMed ID: 3136793
[No Abstract] [Full Text] [Related]
2. Virucidal treatment of clotting factor concentrates.
Mannucci PM; Colombo M
Lancet; 1988 Oct; 2(8614):782-5. PubMed ID: 2901620
[No Abstract] [Full Text] [Related]
3. Effect of dry-heating of coagulation factor concentrates at 80 degrees C for 72 hours on transmission of non-A, non-B hepatitis. Study Group of the UK Haemophilia Centre Directors on Surveillance of Virus Transmission by Concentrates.
Lancet; 1988 Oct; 2(8615):814-6. PubMed ID: 2902265
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.
Heldebrant CM; Gomperts ED; Kasper CK; McDougal JS; Friedman AE; Hwang DS; Muchmore E; Jordan S; Miller R; Sergis-Davenport E
Transfusion; 1985; 25(6):510-5. PubMed ID: 3934800
[TBL] [Abstract][Full Text] [Related]
5. Heat treatment at 100 degrees C of factor VIII and IX coagulation factor concentrates.
Teh LC; Woodfield DG
Med J Aust; 1993 Sep; 159(5):355-6. PubMed ID: 8361441
[No Abstract] [Full Text] [Related]
6. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
Ikematsu S; Yorifuji H; Arai M; Fukutake K
Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
[No Abstract] [Full Text] [Related]
7. Outbreaks of hepatitis A and emergence of new AIDS-associated agents: the need to add terminal 100 degrees C dry-heat sterilization to factor VIII and factor IX concentrates.
Guillaume TA
Vox Sang; 1993; 65(2):158. PubMed ID: 8212671
[No Abstract] [Full Text] [Related]
8. Safety of pasteurised factor VIII (haemate HS).
Delvos V; Weidmann E; Hilfenhaus J; Mauler R
Lancet; 1988 Nov; 2(8620):1141-2. PubMed ID: 2903355
[No Abstract] [Full Text] [Related]
9. Hepatitis B virus associated DNA polymerase inactivation in factor IX concentrates.
Mitra G; Ng PK
Thromb Res; 1986 Feb; 41(3):291-300. PubMed ID: 3705011
[TBL] [Abstract][Full Text] [Related]
10. Detection of factor VIII and IX inhibitors after first exposure to heat-treated concentrates.
Hasegawa DK; Edson JR
Lancet; 1987 Feb; 1(8530):449. PubMed ID: 2880242
[No Abstract] [Full Text] [Related]
11. Factor VIII and IX inhibitors after exposure to heat-treated concentrates.
Pasi KJ; Hamon MD; Perry DJ; Hill FG
Lancet; 1987 Mar; 1(8534):689. PubMed ID: 2882112
[No Abstract] [Full Text] [Related]
12. Post-transfusion hepatits following the use of prothrombin complex concentrates.
Roberts HR; Blatt PM
Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
[No Abstract] [Full Text] [Related]
13. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
Schimpf K
Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
[TBL] [Abstract][Full Text] [Related]
14. Clinical studies with treated clotting factor concentrates.
Colombo M; Mannucci PM
Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
16. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.
Hollinger FB; Dolana G; Thomas W; Gyorkey F
J Infect Dis; 1984 Aug; 150(2):250-62. PubMed ID: 6432922
[TBL] [Abstract][Full Text] [Related]
17. [Plasma concentrates of factor VIII. Where are we?].
Vicente V
Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
[No Abstract] [Full Text] [Related]
18. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
19. Plasma derivatives and viral hepatitis.
Gerety RJ; Aronson DL
Transfusion; 1982; 22(5):347-51. PubMed ID: 6812245
[TBL] [Abstract][Full Text] [Related]
20. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
